TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS BY OVARIECTOMY, INTERFERON ALPHA-2B AND TAMOXIFEN - A CASE-REPORT

被引：20

作者：

KLEIN, M

KRIEGER, O

RUCKSER, R

ROSEN, A

WALDNER, R

PREIS, P

BECK, A

机构：

[1] KRANKENHAUS ELISABETHINEN,DEPT MED 1,LINZ,AUSTRIA

[2] HANUSCH HOSP,LUDWIG BOLTZMANN INST LEUKEMIA RES & HEMATOL,VIENNA,AUSTRIA

[3] DONAUSPITAL SMZ OST,DEPT MED 2,VIENNA,AUSTRIA

[4] DINAUSPITAL SMZ OST,DEPT GYNECOL & OBSTET,VIENNA,AUSTRIA

[5] HANUSCH HOSP,DEPT MED 3,VIENNA,AUSTRIA

[6] KRANKENHAUS WAIDHOFEN,DEPT MED,THAYA,AUSTRIA

来源：

ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 1992年 / 252卷 / 02期

关键词：

LYMPHANGIOLEIOMYOMATOSIS; INTERFERON ALPHA-2B;

D O I：

10.1007/BF02389635

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The gender-specific prevalence of lymphangioleiomyomatosis (LAM) in premenopausal women suggests a hormonal etiology. Despite the antiestrogenic treatment (ovariectomy, tamoxifen) this disease is often refractory to therapy and almost inevitably leads to the patient's death. We describe a case where the antiproliferative effect of systemically applied interferon alpha 2b was successfully employed in addition to ovariectomy and the patient reached complete remission.

引用

页码：99 / 102

页数：4

共 18 条

[1] EFFICACY OF OOPHORECTOMY IN LYMPHANGIOLEIOMYOMATOSIS AND BENIGN METASTASIZING LEIOMYOMA [J].